Table 1.
Baseline characteristics of the study population
| Characteristics | Total (n = 142) |
|---|---|
| Age (years) | 61.3 ± 11.0 |
| Male | 75 (51.8) |
| Comorbidity | |
| Hypertension | 56 (39.4) |
| Diabetes Mellitus | 33 (23.2) |
| Dyslipidemia | 32 (22.5) |
| BMI | 20.3 ± 10.5 |
| Smoking | 34 (23.9) |
| Alcohol | 44 (31.0) |
| EGD indication | |
| Symptom † | 56 (39.4) |
| Screening | 61 (43.0) |
| Alarm feature ‡ | 18 (12.7) |
| Surveillance | 3 (2.1) |
| Endoscopic biopsy indication | |
| Atrophic gastritis | 141 (99.3) |
| Intestinal metaplasia | 119 (83.8) |
| Peptic ulcer | 11 (7.7) |
| Neoplasm of stomach | 55 (38.7) |
† Symptoms include dyspepsia, reflux symptom, and abdominal pain
‡ Alarm features include anemia, dysphagia, weight loss, GI bleeding, vomiting and bowel habit change
Abbreviations: BMI; Body mass index, EGD; Esophagogastroduodenoscopy
Data are presented as number of patients (%) or mean ± SD.